| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |